Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coral Calcium and Ibandronate in Postmenopausal Osteoporosis
NCT04321837Phase 2Completed
- Sponsor
- Columbia University
- Start
- Feb 2020
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in osteoporosis (3 arms), sponsored by Columbia University. Primary endpoints: Mean change in bone mineral density (lumbar spine) at 48 weeks, Mean change in bone mineral density (femoral neck) at 48 weeks and 2 more. Started Feb 2020; status: completed.
02
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04321837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321837.